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This article collates information about the number of scientiﬁc articles
mentioning each of the establishedmedulloblastoma cell lines, derived
through a systematic search of Web of Science, Scopus and Google
Scholar in 2016. The data for each cell line have been presented as raw
number of citations, percentage share of the total citations for each
search engine and as an average percentage between the three search
engines. In order to correct for the time since each cell line has been in
use, the raw citation data have also been divided by the number of
years since the derivation of each cell line. This is a supporting article
for a review of in vitro models of medulloblastoma published in
“in vitro models of medulloblastoma: choosing the right tool for the
job” (D.P. Ivanov, D.A. Walker, B. Coyle, A.M. Grabowska, 2016) [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
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acquiredSystematic search of Web of Science, Google Scholar and Scopus databasesata format Raw, analysed
xperimental
factorsThe name of each cell line was searched along with the term medulloblastomaxperimental
featuresRaw data were transformed to number of citations per year since cell line deri-
vation or publicationata source
locationNottingham, UKata accessibility Data is shared within this articleValue of the data
 The data shows the relative popularity for each of the established medulloblastoma cell lines.
 The most frequently cited cell lines can be easily seen along with the number of papers where they
are mentioned.
 In conjunction with the review article, the data can be used to link cell lines and medulloblastoma
subtypes.
 Researchers can readily identify underrepresented medulloblastoma subtypes, such as WNT and
Group 4.
 The relative merits of using Google Scholar, Web of Science and Scopus to ﬁnd information about
speciﬁc cell lines can be compared.1. Data
Data are organised in three spreadsheets within one Excel ﬁle. The “Raw Citations” spreadsheet
gives the numbers of citations for each cell line as determined by a search of Google Scholar, Web of
Science and Scopus databases. It also includes the date of derivation for each cell line and the dif-
ference with the current year (2016). The second spreadsheet named “Analysis” includes a calculation
of the relative percentage of the citations for each cell line compared to the total number of citations;
ﬁrst for each search engine, and then as a mean of the percentage results for all three search engines.
The same procedure is applied to the citation data divided by the number of years since the ﬁrst
publication of the cell line. Cell lines are then ranked for their relative popularity both before and after
correcting for the time they have been in use. The ranks have been used to create the pie charts
displaying the relative frequency of scientiﬁc mentions for the 15 most popular cell lines in Figure 2 of
[1]. The third spreadsheet contains a table of the four medulloblastoma subtypes along with their
reported relative frequency in patients [2,3].2. Experimental design, materials and methods
Web of Science, Scopus and Google scholar databases were searched using the name of each cell
line and the term medulloblastoma. The number of all citations in Google Scholar and the number of
original articles (Web of Science, Scopus) mentioning the keywords were documented for each cell
line. Wildcards were used to ﬁnd citations encompassing the different ways of spelling the cell lines.
For example “D$283 and medulloblastoma” to ﬁnd all mentions of “D-283, D 283 or D283”. The
advantage of Web of Science and Scopus are that only original articles can be selected, while Google
Scholar includes “grey literature”, such as conference proceedings and scientiﬁc posters. Nevertheless,
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without them necessarily being mentioned in the topic, abstract or keywords.
The list of medulloblastoma cell lines was compiled from Cellosaurus, the controlled vocabulary of
cell lines developed by the Swiss Institute of Bioinformatics [4], and the review by Xu et al. [5]. The
relative percentage of citations for each cell line was determined separately for each database and
reported as the mean percentage for three databases. The time of the ﬁrst publication was used to
determine the number of years the cell line has been available for, and the difference with the current
year (2016) was used to normalise the citation data.Acknowledgements
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